These results indicate that the transmembrane FGFR4 variants can modulate cell growth and sensitivity to glucocorticoid hormone negative feedback through various STAT3 modifications relevant to human forms of Cushing’s syndrome [30]. Here, STAT3 is linked to Cushing syndrome.